Literature DB >> 6164380

Characterization of human sarcoma antigen S3.

J K Sethi, Y Hirshaut.   

Abstract

An antigen common to human sarcomas, S3, has been further characterized. It is antigenically distinct from human blood-group substances A and B and from heterophile antigens such as Forssman, infectious mononucleosis and serum sickness antigens. Whilst S3 antigen preparations may contain small amounts of CEA and AFP there is no correlation between S3 antigen and the presence or amount of these known tumour-associated substances. S3 antibody can be fully absorbed with guinea-pig kidney but not boiled beef or SRBC. S3, therefore, is a heterophile substance which has not previously been identified. A seroepidemiological survey confirms that S3-antibody prevalence is significantly increased in persons with a wide variety of malignant disease, as well as in family members of patients with sarcoma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164380      PMCID: PMC2010596          DOI: 10.1038/bjc.1981.43

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Forssman-like antibody levels in sera of patients with lung cancer.

Authors:  H Kitamura; P Levine; P J Cheng; R A Egeli; Y P Liu; R A Good; N K Day
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

2.  Seroepidemiology of human sarcoma antigen (S1).

Authors:  Y Hirshaut; D T Pei; R C Marcove; B Mukherji; A R Spielvogel; E Essner
Journal:  N Engl J Med       Date:  1974-11-21       Impact factor: 91.245

3.  Studies on heterophile antigen in lymphoma and leukemia spleens by means of absorption of infectious mononucleosis sera.

Authors:  F Milgrom; K Kano; A Fjelde
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

4.  Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia.

Authors:  T A Waldmann; K R McIntire
Journal:  Lancet       Date:  1972-11-25       Impact factor: 79.321

5.  Association of herpes-like virus infection with infectious mononucleosis.

Authors:  Y Hirshaut; P Glade; H Moses; R Manaker; L Chessin
Journal:  Am J Med       Date:  1969-10       Impact factor: 4.965

6.  Procedures for control of mycoplasma contamination of tissue cultures.

Authors:  J Fogh; H Fogh
Journal:  Ann N Y Acad Sci       Date:  1969-12-16       Impact factor: 5.691

7.  Variation in expression of S3 antigen in human sarcoma cell lines: influence of passages and medium on generation of S3.

Authors:  J K Sethi; Y Hirshaut
Journal:  Eur J Cancer       Date:  1978-11       Impact factor: 9.162

8.  Growing human sarcomas in culture.

Authors:  J Sethi; Y Hirshaut; S I Hajdu; L G Clements
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

9.  Heterophile antibodies in pathologic human sera resembling antibodies stimulated by foreign species sera.

Authors:  R Kasukawa; K Kano; M L Bloom; F Milgrom
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

10.  Complement-fixing antigen of human sarcomas.

Authors:  J Sethi; Y Hirshaut
Journal:  J Natl Cancer Inst       Date:  1976-09       Impact factor: 13.506

View more
  1 in total

1.  Toxicological response of the model fungus Saccharomyces cerevisiae to different concentrations of commercial graphene nanoplatelets.

Authors:  Maria Suarez-Diez; Santiago Porras; Felix Laguna-Teno; Peter J Schaap; Juan A Tamayo-Ramos
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.